MLYS
Mineralys Therapeutics Inc

516
Mkt Cap
$3.33B
Volume
1.62M
52W High
$47.65
52W Low
$8.24
PE Ratio
-14.24
MLYS Fundamentals
Price
$41.87
Prev Close
$42.12
Open
$42.91
50D MA
$40.51
Beta
0.00
Avg. Volume
1.07M
EPS (Annual)
-$3.66
P/B
5.77
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Mineralys Therapeutics (NASDAQ:MLYS) Shares Up 9% - Should You Buy?
Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 9% - Still a Buy...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Profund Advisors LLC Makes New Investment in Mineralys Therapeutics, Inc. $MLYS
Profund Advisors LLC purchased a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·2d ago
News Placeholder
Candriam S.C.A. Lowers Position in Mineralys Therapeutics, Inc. $MLYS
Candriam S.C.A. lessened its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 6.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm...
MarketBeat·5d ago
News Placeholder
Mineralys Therapeutics (NASDAQ:MLYS) Director Sells $323,909.76 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Alexander Gold sold 6,933 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $5,364,237.12 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CFO Adam Scott Levy sold 119,524 shares of Mineralys Therapeutics stock in a transaction that occurred on Tuesday, November 11th. The...
MarketBeat·5d ago
News Placeholder
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) CEO Sells $9,088,000.00 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CEO Jon Congleton sold 200,000 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an...
MarketBeat·5d ago
News Placeholder
Alexander Gold Sells 12,742 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Alexander Gold sold 12,742 shares of Mineralys Therapeutics stock in a transaction dated Thursday, November 13th. The shares were...
MarketBeat·5d ago
News Placeholder
Mineralys Therapeutics (NASDAQ:MLYS) Director Alexander Gold Sells 15,000 Shares
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Alexander Gold sold 15,000 shares of the company's stock in a transaction dated Tuesday, November 11th. The shares were sold at...
MarketBeat·5d ago
News Placeholder
Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells $689,850.00 in Stock
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Daphne Karydas sold 15,000 shares of the stock in a transaction dated Thursday, November 13th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
Mineralys Therapeutics (NASDAQ:MLYS) Sees Large Volume Increase - Still a Buy?
Mineralys Therapeutics (NASDAQ:MLYS) Sees Strong Trading Volume - Should You Buy...
MarketBeat·5d ago

Latest MLYS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.